Results 141 to 150 of about 192 (165)

GL3, a Novel 4β-Anilino-4'-O-Demethyl-4-Desoxypodophyllotoxin Analog, Traps Topoisomerase II Cleavage Complexes and Exerts Anticancer Activities. [PDF]

Transl Oncol, 2013
Yang XC, Qian SJ, Wang L, Liao SD, Cao J, Hu YZ, He QJ, Zhu H, Yang B.   +8 more
europepmc   +1 more source

Resveratrol Reverses Functional Chagas Heart Disease in Mice. [PDF]

PLoS Pathog, 2016
Vilar-Pereira G, Carneiro VC, Mata-Santos H, Vicentino AR, Ramos IP, Giarola NL, Feijó DF, Meyer-Fernandes JR, Paula-Neto HA, Medei E, Bozza MT, Lannes-Vieira J, Paiva CN.   +12 more
europepmc   +1 more source

Metabolic cardioprotectors in sport: the focus on last changes in WADA Prohibited List (review)

Sporto mokslas / Sport Science, 2016
openaire   +1 more source

Potential Strategies for Overcoming Drug Resistance Pathways Using Propolis and Its Polyphenolic/Flavonoid Compounds in Combination with Chemotherapy and Radiotherapy. [PDF]

Nutrients
Oršolić N, Jazvinšćak Jembrek M.
europepmc   +1 more source

Efecto cardioprotector de la octilguanidina

, 2004
openaire   +1 more source

Eficacia y seguridad del dexrazoxane como cardioprotector en niños mexicanos con cancer

, 2002
openaire   +1 more source

Some of the next articles are maybe not open access.

Related searches:

Efectos cardioprotectores del ticagrelor

Revista Española de Cardiología Suplementos, 2017
El desarrollo de los inhibidores del receptor plaquetario P2Y12 ha sido fundamental para el tratamiento de los pacientes con sindrome coronario agudo. En los ultimos anos, multiples evidencias experimentales y clinicas sustentan que los inhibidores del receptor P2Y12 ejercen efectos pleotropicos mas alla de sus propiedades antiagregantes plaquetarias ...
Lina Badimona, Gemma Vilahur
openaire   +1 more source

Purpurogallin: In vivo evidence of a novel and effective cardioprotector

Life Sciences, 1994
We observed that purpurogallin (PPG) which is a flavonoid markedly protects the rabbit against myocardial ischemia-reperfusion injury. In rabbits undergoing 1-h ligation of the anterior ventricular coronary artery, a bolus infusion of PPG was introduced into the post-ischemic heart immediately before 3-h reperfusion.
T W, Wu, J, Wu, L H, Zeng, J X, Au, D, Carey, K P, Fung   +5 more
openaire   +2 more sources

Cardioprotector Activity of an Esteroidal Saponin: A Scientific and Technological Prospection

Recent Patents on Biotechnology, 2017
Cardiovascular diseases are a group of disorders of the heart and blood vessels that account for a major cause of premature death worldwide. Diosgenin saponin is a steroid for therapeutic application in different clinical settings such as cardiovascular diseases, hyperglycemia and dyslipidemia control, antimicrobial, anti-viral and anti-inflammatory ...
Michely Laiany Vieira, Moura, Aldeidia, Pereira de Oliveira, Hercília Maria Lins, Rolim   +2 more
openaire   +2 more sources

Carvedilol: Just Another Beta-Blocker or a Powerful Cardioprotector?

Cardiovascular & Hematological Disorders-Drug Targets, 2006
Beta-blockers have been used to treat ischemic heart disease, due to negative chronotropic and inotropic properties, thus inducing a decrease in myocardial consumption of oxygen and nutrients, allowing a better balance between nutritional needs and the supply provided by the coronary blood flow.
R S, Carreira, P, Monteiro, L M, Gon Alves, L A, Providência   +3 more
openaire   +2 more sources